IRS
Pharmaceuticals
3 / A : Adequate Resilience
Healthcare Industry Risk
Medium Risk
Construction Industry Risk
High Risk
Retail Industry Risk
Medium Risk
Report #005
Technology Industry Risk
Low Risk
Report #006
Energy Industry Risk
High Risk